Pancreatic Cancer Research

ResearcherZhejiang Shuren UniversityActive in the last 2 years

Qiyong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7203-3707; OpenAlex author ID A5047572104. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 3

  1. A case of annular pancreas complicated with pancreatic ductal adenocarcinoma diagnosed with linear endoscopic ultrasound. Co-author DOI 10.1055/a-2603-7352↗
  2. Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer: A Real-World, Single-Center… Last author DOI 10.2147/ott.s427942↗
  3. The role of cancer-associated fibroblast MRC-5 in pancreatic cancer. Last author DOI 10.7150/jca.19614↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Songming Ding · 2 shared papers, 2018–2025 · strength 0.39
  2. Hua Guo · 1 shared paper, 2025 · strength 0.30
  3. Min Xiao · 1 shared paper, 2023 · strength 0.20
  4. Zhitao Chen · 1 shared paper, 2023 · strength 0.20
  5. Jun Chen · 1 shared paper, 2023 · strength 0.20
  6. Lin Zhou · 1 shared paper, 2018 · strength 0.09
  7. Shusen Zheng · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.